Tag: ovarian cancer

Latest News

Study compares cediranib plus olaparib and standard of care therapy for platinum-sensitive ovarian cancer

Newsemia
Results of the NRG Oncology phase III clinical trial NRG-GY004 indicated that the addition of the investigational agent cediranib to olaparib and standard platinum-based chemotherapy...
Latest News

Financial Toxicity Is Common With Gynecologic Cancers

Newsemia
More than one fifth of patients who are treated for gynecologic malignancies experience financial toxicity, results of a single-center study suggest. Source link...
Latest News

Advanced Ovarian Cancer: Survival & NAC Use Continue to Increase

Newsemia
Survival of patients with advanced ovarian cancer continues to increase, despite concerns that increased use of neoadjuvant chemotherapy (NAC) could have a negative impact on...
Latest News

Purdue-developed 'fluorescent markers' begin Phase 3 clinical trials

Newsemia
On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has...
Latest News

Women’s Heart Fund announces launch of ‘Community Conversations with the CDI’

Newsemia
The Women’s Heart Fund, a philanthropic arm of Hackensack Meridian Health Meridian Health Foundation, has announced that for its newest venture, the organization will sponsor...
Latest News

A protein found in ovarian cancer may contribute to neurodegeneration in Alzheimer's disease

Newsemia
Houston Methodist scientists identified a protein found in ovarian cancer that may contribute to declining brain function and Alzheimer’s disease, by combining computational methods and...
Latest News

Study may provide novel targetable mechanisms of therapeutic resistance to anti-VEGF therapies

Newsemia
To establish a molecular signature of this resistance in ovarian cancer, the authors developed preclinical tumor models of adaptive resistance to chronic anti-VEGF treatment. Source...
Latest News

Novel therapeutic approach improves survival in patients newly diagnosed with advanced ovarian cancer

Newsemia
An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed with advanced ovarian cancer, improves their progression-free survival, and reduces...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World